Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
71 /100
HIGH RISK
Score updated Aug 28, 2026

ELTX — Elicio Therapeutics, Inc. Dilution Risk Tracker

Track ELTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ELTX — Get alerts when the score changes →

As of August 28, 2026, Elicio Therapeutics, Inc. (ELTX) has a DilutionWatch DilutionScore of 71/100, rated HIGH dilution risk. Elicio Therapeutics, Inc. has a market capitalization of $218.34M, 26.28M shares outstanding, 49 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $400.00M, ATM program capacity of $100.00M, 1.26M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 29%
💰 Capital Raise model 53%
• Under 12 months cash (7mo)
• Active shelf registration ($400M, 183% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (71/100)
🔔 Track ELTX — Get forecast alerts →

Market Data

Market Cap$218.34M
Shares Outstanding26.28M
Float13.19M
Cash$23.48M
Debt$9.54M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 49.0% shares (2026Q1 vs prior)
49 institutional holders · 3.67M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.04M shares
#2 Knoll Capital Management, LLC 630.9K shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 373.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.75M
Days to Cover5.1
% of Float13.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2025-12-31
424B5 ATM 2026-03-16
8-K 8K EVENT 2026-03-16
EFFECT EFFECT 2026-03-16
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ELTX Dilution Snapshot

Elicio Therapeutics, Inc. (ELTX) has a DilutionScore of 71/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ELTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ELTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ELTX
ELTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.